MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on February 9, 2005; DOI: 10.1124/mol.104.008185


0026-895X/05/6705-1470-1484$20.00
Mol Pharmacol 67:1470-1484, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.008185v1
67/5/1470    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, P. E.
Right arrow Articles by Wyllie, D. J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, P. E.
Right arrow Articles by Wyllie, D. J. A.
ORIGINAL ARTICLE

Structural Features of the Glutamate Binding Site in Recombinant NR1/NR2A N-Methyl-D-aspartate Receptors Determined by Site-Directed Mutagenesis and Molecular Modeling

Philip E. Chen, Matthew T. Geballe, Phillip J. Stansfeld, Alexander R. Johnston, Hongjie Yuan, Amanda L. Jacob, James P. Snyder, Stephen F. Traynelis, and David J. A. Wyllie

Division of Neuroscience, University of Edinburgh, Edinburgh, United Kingdom (P.E.C., P.J.S., A.R.J., D.J.A.W.); Department of Chemistry, Emory University, Atlanta, Georgia (M.T.G., J.P.S.); and Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, Atlanta, Georgia (H.Y., A.L.J., S.F.T.)

Abstract

We have used site-directed mutagenesis of amino acids located within the S1 and S2 ligand binding domains of the NR2A N-methyl-D-aspartate (NMDA) receptor subunit to explore the nature of ligand binding. Wild-type or mutated NR1/NR2A NMDA receptors were expressed in Xenopus laevis oocytes and studied using two electrode voltage clamp. We investigated the effects of mutations in the S1 and S2 regions on the potencies of the agonists L-glutamate, L-aspartate, (R,S)-tetrazol-5yl-glycine, and NMDA. Mutation of each of the corresponding residues found in the NR2A receptor subunit, suggested to be contact residues in the GluR2 {alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunit, caused a rightward shift in the concentration-response curve for each agonist examined. None of the mutations examined altered the efficacy of glutamate as assessed by methanethiosulfonate ethylammonium potentiation of agonist-evoked currents. In addition, none of the mutations altered the potency of glycine. Homology modeling and molecular dynamics were used to evaluate molecular details of ligand binding of both wild-type and mutant receptors, as well as to explore potential explanations for agonist selectivity between glutamate receptor subtypes. The modeling studies support our interpretation of the mutagenesis data and indicate a similar binding strategy for L-glutamate and NMDA when they occupy the binding site in NMDA receptors, as has been proposed for glutamate binding to the GluR2 AMPA receptor subunit. Furthermore, we offer an explanation as to why "charge conserving" mutations of two residues in the binding pocket result in nonfunctional receptor channels and suggest a contributing molecular determinant for why NMDA is not an agonist at AMPA receptors.


Received October 20, 2004; accepted February 8, 2005

Address correspondence to: Dr. David J. A. Wyllie, Division of Neuroscience, University of Edinburgh, 1 George Square, Edinburgh, EH8 9JZ, United Kingdom. E-mail: dwyllie1{at}staffmail.ed.ac.uk




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. V. Kenny, S. L. Cousins, L. Pinho, and F. A. Stephenson
The Integrity of the Glycine Co-agonist Binding Site of N-Methyl-D-aspartate Receptors Is a Functional Quality Control Checkpoint for Cell Surface Delivery
J. Biol. Chem., January 2, 2009; 284(1): 324 - 333.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. L. Blanke and A. M. J. VanDongen
Constitutive Activation of the N-Methyl-D-aspartate Receptor via Cleft-spanning Disulfide Bonds
J. Biol. Chem., August 1, 2008; 283(31): 21519 - 21529.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. L. Blanke and A. M. J. VanDongen
The NR1 M3 Domain Mediates Allosteric Coupling in the N-Methyl-D-aspartate Receptor
Mol. Pharmacol., August 1, 2008; 74(2): 454 - 465.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H.-R. Chang and C.-C. Kuo
The Activation Gate and Gating Mechanism of the NMDA Receptor
J. Neurosci., February 13, 2008; 28(7): 1546 - 1556.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. C. Wrighton, E. J. Baker, P. E. Chen, and D. J. A. Wyllie
Mg2+ and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes
J. Physiol., January 1, 2008; 586(1): 211 - 225.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
P. E. Chen, M. T. Geballe, E. Katz, K. Erreger, M. R. Livesey, K. K. O'Toole, P. Le, C. J. Lee, J. P. Snyder, S. F. Traynelis, et al.
Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes
J. Physiol., January 1, 2008; 586(1): 227 - 245.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. Erreger, M. T. Geballe, A. Kristensen, P. E. Chen, K. B. Hansen, C. J. Lee, H. Yuan, P. Le, P. N. Lyuboslavsky, N. Micale, et al.
Subunit-Specific Agonist Activity at NR2A-, NR2B-, NR2C-, and NR2D-Containing N-Methyl-D-aspartate Glutamate Receptors
Mol. Pharmacol., October 1, 2007; 72(4): 907 - 920.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Maier, R. Schemm, C. Grewer, and B. Laube
Disruption of Interdomain Interactions in the Glutamate Binding Pocket Affects Differentially Agonist Affinity and Efficacy of N-methyl-D-aspartate Receptor Activation
J. Biol. Chem., January 19, 2007; 282(3): 1863 - 1872.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Wada, H. Takahashi, S. A. Lipton, and H.-S. V. Chen
NR3A Modulates the Outer Vestibule of the "NMDA" Receptor Channel
J. Neurosci., December 20, 2006; 26(51): 13156 - 13166.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. A. Frizelle, P. E. Chen, and D. J. A. Wyllie
Equilibrium Constants for (R)-[(S)-1-(4-Bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic Acid (NVP-AAM077) Acting at Recombinant NR1/NR2A and NR1/NR2B N-Methyl-D-aspartate Receptors: Implications for Studies of Synaptic Transmission
Mol. Pharmacol., September 1, 2006; 70(3): 1022 - 1032.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. J. A. Wyllie, A. R. Johnston, D. Lipscombe, and P. E. Chen
Single-channel analysis of a point mutation of a conserved serine residue in the S2 ligand-binding domain of the NR2A NMDA receptor subunit
J. Physiol., July 15, 2006; 574(2): 477 - 489.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. B. Hansen, R. P. Clausen, E. J. Bjerrum, C. Bechmann, J. R. Greenwood, C. Christensen, J. L. Kristensen, J. Egebjerg, and H. Brauner-Osborne
Tweaking Agonist Efficacy at N-Methyl-D-aspartate Receptors by Site-Directed Mutagenesis
Mol. Pharmacol., December 1, 2005; 68(6): 1510 - 1523.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics